** Shares of Alzchem GroupACT1.DE slip 2.7% in early Frankfurt trade after the German specialty chemicals producer published what a local trader calls a "mixed" set of FY results
** The group's sales grow 1.4% to 562 million euros ($663.27 million), which is below expectations according to the trader, while EBITDA of 116.5 million euros meets forecasts
** The 2026 outlook of 6.7% sales growth also falls short of expectations according to the trader
** Alzchem sits at the bottom of the German small-cap index .SDAXi
($1 = 0.8473 euros)
(Reporting by Simon Ferdinand Eibach)
((Simonferdinand.eibach@thomsonreuters.com))